Stephanie Krebs
Vermogen: - $ op 30-06-2026
Vermogen: - $ op 30-06-2026
Stephanie Krebs is currently Chief Business Officer at Sensei Biotherapeutics, Inc. since 2023.
Formerly, Ms. Krebs was Chief Business Officer at SNIPR Biome ApS from 2022 to 2023.
Education includes graduate studies at The Johns Hopkins University, undergraduate studies at Rochester Christian University, and an MBA from the University of Rochester Simon Business School.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Corporate Officer/Principal | 01-11-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
SNIPR Biome ApS
SNIPR Biome ApS Pharmaceuticals: MajorHealth Technology Develops bacterial composition to provide treatment for diabetes to cancer | Corporate Officer/Principal | 01-10-2023 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Rochester Simon Business School
University of Rochester Simon Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SNIPR Biome ApS
SNIPR Biome ApS Pharmaceuticals: MajorHealth Technology Develops bacterial composition to provide treatment for diabetes to cancer | Health Technology |
Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau